Growth Metrics

InspireMD (NSPR) Current Deferred Tax Assets (2015 - 2016)

InspireMD posted quarterly Current Deferred Tax Assets of $98000.0 for Q4 2016, down 45.25% year-on-year from $179000.0 in Q1 2016, and down 45.25% on a QoQ basis from $179000.0 in Q4 2015.

InspireMD (NSPR) has 2 years of Current Deferred Tax Assets data on file, last reported at $98000.0 in Q4 2016.

  • For the quarter ending Q4 2016, Current Deferred Tax Assets fell 45.25% year-over-year to $98000.0; the trailing twelve-month figure through Dec 2016 stood at $98000.0 (down 45.25% YoY), and the FY2016 full-year result was $98000.0, down 45.25% from the prior year.
  • Current Deferred Tax Assets for Q4 2016 stood at $98000.0, down from $179000.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $179000.0 in Q4 2015 and bottomed at $98000.0 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 98,000.00
Dec 31, 2016 98,000.00
Dec 31, 2015 179,000.00
Dec 31, 2015 179,000.00